Skip to content
value.today

AltrixBio, Inc.

Total raised
$1 M
1 round on record
Latest round
$1 M
Apr 2025
First round on record
Apr 2025
Today
Private
No later event on record

Funding rounds

1 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of AltrixBio, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Apr 2025$1 MNo. 1Under $2 million

AltrixBio, Inc.: Raise no. 1, Apr 2025

Investors in this round

20 investors had bought by the notice of Jun 16, 2025.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $10 M offered; $9 M still to sell
Smallest investment taken
$10,000
What was sold
equity
Exemption claimed
  • Rule 504: up to $10 million in twelve months
  • Rule 506(c): may be advertised publicly; every buyer must be a verified accredited investor
  • Section 4(a)(5): accredited investors only, up to $5 million, no public advertising
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
$250,000
Paid to its own people
$75,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks finders' fees and payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Nancy Briefs · Executive Officer, Director
  • Ali Tavakkoli · Director
  • Jeffrey Karp · Director
  • John Brooks · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Nancy Briefs, President and Director. Newest notice filed Jun 16, 2025. Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • AltrixBio, Inc. chose not to state its revenue in its newest notice of a funding round (Jun 2025).

    SEC Form D · Jun 2025

  • The industry group it chose in its notices: Pharmaceuticals.

    SEC Form D · Jun 2025

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of AltrixBio, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by AltrixBio, Inc.
NameRoleNamed in
Nancy BriefsExecutive officerJun 2025
Ali TavakkoliDirectorJun 2025
Jeffrey KarpDirectorJun 2025
John BrooksDirectorJun 2025
Nancy BriefsDirectorJun 2025